PYC Therapeutics financials at a glance

Year Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2020 2021 2019 2022 2024 2023
Rev. Revenue
$0.05M $0.49M $0.94M $0.87M $1.27M $0.60M $2.36M $1.92M $0.71M $0.74M $0.83M $0.00M $2.76M $0.05M $2.40M $3.07M $0.00M $16.04M $0.00M $15.81M
GM % Gross Margin %
31.04% -21.17% 12.90% 34.59% 10.25% 0.00% -28.84% -58.58% 0.00% 0.00% 0.00% 0.00% -69.11% 0.00% 98.70% 100.00% 0.00% 100.00% 0.00% 100.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% -290.41% 0.00% -157.63% -211.95% 0.00% 0.00% 0.00% 0.00% -153.89% 0.00% 0.00% 0.00% 0.00% -89.05% 0.00% -148.24%
EPS Earnings Per Share
$-0.02 $-0.01 $-0.01 $-0.01 $-0.00 $-0.01 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 0 0 -0.00% -0.00% -0.00% 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
0m 107.86m 108.62m 140.76m 163.75m 235.75m 283m 445.89m 446.89m 580.73m 1002.07m 2004.14m 2004.14m 2135.52m 2931.43m 3170.93m 2442.86m 3180.93m 3732.87m 3180.93m
OCF Operating Cash Flow
$-1.33M $-2.81M $-3.09M $-4.97M $-3.88M $-3.63M $-2.94M $-4.15M $-2.32M $-3.20M $-2.48M $-3.17M $-1.88M $-6.71M $-5.75M $-11.79M $-5.13M $-21.78M $0.00M $-24.42M
FCF Free Cash Flow
$-1.37M $-2.86M $-3.16M $-5.10M $-3.89M $-3.79M $-3.13M $-4.50M $-2.58M $-3.40M $-2.54M $-3.20M $0.00M $-6.92M $-5.86M $-12.38M $-5.59M $-22.17M $0.00M $-24.91M
FCFS Free Cash Flow Per Share
$-0.02 $-0.03 $-0.03 $-0.04 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.01 $0.00 $-0.01